Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19

NCT04918927 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Covid19

Interventions

DRUG: Favipiravir
DRUG: Nitazoxanide
OTHER: Nitazoxanide Placebo

Sponsor

Coordinación de Investigación en Salud, Mexico

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]